Oura is in business.
What’s happening: The smart ring maker made its IPO filing public, revealing a business growing 74% YoY and global membership topping 5M.
Scale. Oura sold 3.6M rings in the past 12 months, generating $1.4B+ in revenue and $60M in net income over that time. While hardware accounts for ~80% of revenue, membership grew 121% to $241M, with an 89% gross margin.
Market. Only ~2% of global wearable shipments are Oura, but the company estimates its serviceable market to be >$90B. Selling itself, 40% of member acquisition is organic, and 33% of new members are first-time wearable buyers.
AI. Positioning as an “always-on health intelligence platform” for the preventative health era, it seeks to develop proprietary AI models to deliver more personalized health insights and enable consumers to make their own decisions.
With women making up 72% of its membership, its first model focuses on women’s health, expanding from cycle and fertility tracking into pregnancy and menopause — while pushing its data into healthcare through provider partnerships. Additional models are in development.
The bigger bet. Adding to medical-grade features, clinical partnerships, and a proposed “cloud of wearables,” Oura’s ace is its accumulation of 42B+ hours of biometric data.
Leveraging real, continuous insight over population-level reports, it becomes the bridge between individual and institution — making trials more representative, treatment more specific, and health more personal.
Punchline: Oura is going public as a scaled wearable business, but its expected $16B valuation goes far beyond the ring.
